https://sciex.com/content/SCIEX/na/us/en


It’s a Point and Click World with the X500B QTOF System for Biologics Characterization

Feb 15, 2017 | Biopharma, Blogs | 0 comments

Did you know the X500B QTOF system makes point and click workflows for Biologics Characterization possible on your mass spectrometer? The newly-designed SCIEX OS software interface brings to life fluid navigation and ease of use so you can keep moving forward on your scientific discoveries. In fact, it’s so simple to learn and operate that you and your team can be up and running faster than you might expect.

Hard to believe? Check out our new video series and see how easy it can be to get started with SCIEX OS on the X500B QTOF system.

Move Your Biotherapeutic Along Faster
What’s different with the X500B? The new SCIEX OS software was built from the ground up to facilitate the X500B’s usability for every scientist, not just mass spec expertsThe software uses an intuitive, icon-oriented interface so you can logically set up and optimize new methods. Instead of spending time and money on advanced training, you simply get to work. What’s more, SCIEX OS software features simple point and click method-building tools to create and optimize high-performance methods.

Let Your Productivity Soar the X500B QTOF and SCIEX OS Software:

  • Enjoy the no-worry sample queue, which seamlessly incorporates protein calibration into your methods to ensure mass accuracy, even over large batches of samples
  • Use the SCIEX OS Explorer function to quickly visualize and review data during acquisition, in real time
  • Connect to BioPharmaView data processing software for fast answers to your characterization questions

You’ll be surprised how simple it is to increase your productivity.

Watch the short SCIEX OS introduction video series to see how easy it is for you to get fast, high-quality results in the point and click world.

 

Questions and answers to help improve your mycotoxin analysis

During a recent webinar I shared method details for mycotoxin analysis on the SCIEX 7500 system. In this blog i will share the Q&A for the submitted questions that we did not have chance to answer during the live webinar.

A 2-fold revolution: MS approaches for the bioanalysis of oligonucleotide therapeutics

In 1998, the US Food and Drug Administration (FDA) approved fomivirsen as the first therapeutic oligonucleotide therapeutic. This approval marked a revolution of mechanism of action discovered decades before finally coming to fruition. Since then, the landscape of chemical modifications of oligonucleotides, conjugations and formulations has evolved tremendously, contributing to improvements in stability, efficacy and safety. Today, more than a dozen antisense oligonucleotides (ASOs) and small interfering RNA (siRNA) drugs are on the market, most of which are designated as orphan drugs for treating rare genetic diseases.

Is “right first time, every time” a pipedream for metabolite identification by LC-MS?

If we lived in an ideal world, it would be possible to unambiguously identify metabolites using a single analytical experiment. This analytical technique would need to be efficient and easily generate the information needed from a routine assay that is also robust, enabling confident decision-making during drug discovery.

Posted by

0 Comments

Submit a Comment

Wordpress Social Share Plugin powered by Ultimatelysocial